Shandong Weigao Group Medical Polymer Company Limited
Built from real-time financials and updated daily. For a full Analyst Grade with bull/bear case, price targets, and qualitative risk analysis, generate a SHWGY research report →
Companywww.weigaogroup.com
Shandong Weigao Group Medical Polymer Company Limited engages in the research and development, production, and sale of single-use medical devices in the People's Republic of China. It operates through Medical Device Products, Orthopaedic Products, Interventional Products, Pharma Packaging Products, Blood Management Products, and Others segments. The company offers vascular and non-vascular access infusion devices, infusion sets, syringes, puncture needles, and specialized single-use clinical collection kits; wound sutures, wound healing dressings, and wound cleaning and nonvascular catheter supporting extracorporeal devices; and blood collection, storage, separation, and sterilization equipment.
- CEO
- Rinan Cong
- IPO
- 2012
- Employees
- 12,719
- HQ
- Weihai, CN
Price Chart
Valuation
- Market Cap
- $1.83B
- P/E
- 8.82
- P/S
- 1.02
- P/B
- 0.59
- EV/EBITDA
- 3.86
- Div Yield
- 6.83%
Profitability
- Gross Margin
- 47.26%
- Op Margin
- 12.69%
- Net Margin
- 12.04%
- ROE
- 6.69%
- ROIC
- 4.48%
Growth & Income
- Revenue
- $13.02B · -0.48%
- Net Income
- $1.57B · -24.12%
- EPS
- $1.40 · -23.91%
- Op Income
- $1.83B
- FCF YoY
- -19.82%
Performance & Tape
- 52W High
- $3.51
- 52W Low
- $1.60
- 50D MA
- $2.00
- 200D MA
- $2.64
- Beta
- 0.34
- Avg Volume
- 645
Get TickerSpark's AI analysis on SHWGY
Pro members can request AI-generated analysis on any ticker — technical setup, analyst consensus, earnings watch, insider pulse, financial health, and peer context. Ready in about a minute.
Get Pro Access →30-day money-back guarantee · cancel anytime
Our SHWGY Coverage
We haven't published any research on SHWGY yet
For a full analyst-grade research report — grades, price targets, full financials, chart analysis — generate one on demand.
Generate SHWGY Report →